BIOTECHNOLOGY VALUE FUND L P - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Forte Biosciences, Inc. (FBRX)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
Forte Biosciences, Inc. Common Stock, $0.001 par value
Symbol
FBRX
Shares outstanding
6.44M shares
Disclosed Ownership
644K shares
Ownership
9.99%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 04:11 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 5.3% 339K 0 339K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 5.3% 339K 0 339K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 4.1% 262K 0 262K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 4.1% 262K 0 262K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.5% 30.9K 0 30.9K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.5% 30.9K 0 30.9K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 9.3% 601K 0 601K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 9.99% 644K 0 644K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 9.99% 644K 0 644K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 9.99% 644K 0 644K /s/ Mark N. Lampert Mark N. Lampert